An Alternatively Spliced Gain-of-Function NT5C2 Isoform Contributes to Chemoresistance in Acute Lymphoblastic Leukemia

Torres-Diz, M., Reglero, C., Falkenstein, C. D., Castro, A., Hayer, K. E., Radens, C. M., Quesnel-Vallières, M., Ang, Z., Sehgal, P., Li, M. M., Barash, Y., Tasian, S. K., Ferrando, A., & Thomas-Tikhonenko, A. (2024). An Alternatively Spliced Gain-of-Function NT5C2 Isoform Contributes to Chemoresistance in Acute Lymphoblastic Leukemia. Cancer Research. https://doi.org/10.1158/0008-5472.can-23-3804
Authors:
Manuel Torres-Diz
Clara Reglero
Catherine D Falkenstein
Annette Castro
Katharina E Hayer
Caleb M Radens
Mathieu Quesnel-Vallières
Zhiwei Ang
Priyanka Sehgal
Marilyn M Li
Yoseph Barash
Sarah K Tasian
Adolfo Ferrando
Andrei Thomas-Tikhonenko
Affiliated Authors:
Clara Reglero
Adolfo Ferrando
Columbia Affiliation:
Subjects:
Epidemiology and Treatment of Childhood Leukemia (OpenAlex Topic)
RNA Methylation and Modification in Gene Expression (OpenAlex Topic)
Nucleotide Metabolism and Enzyme Regulation (OpenAlex Topic)
elink
Publication Type:
Article
Unique ID:
10.1158/0008-5472.can-23-3804
PMID:
39094066
DOI:
10.1158/0008-5472.can-23-3804
Journal:
Cancer Research
Publication Date:
Data Source:
PubMed
Source Link:
View PubMed Record
View OpenAlex Record

Record Created: